Polade la TorreMDFIDSA

Infectious Disease • Camden, NJ

Associate Professor of Medicine, Cooper Medical School of Rowan University

Join to view full profile

Dr. de la Torre is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. de la Torre's full profile

Already have an account?

Office
3 Cooper Plz
Suite 513
Camden, NJ 08103
Phone+1 856-963-3715

Fax+1 856-635-1052
Is this information wrong?

Education & Training

Temple University HospitalFellowship, Infectious Disease, 2001 - 2003
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1994 - 1997
Georgetown University School of MedicineClass of 1994

Certifications & Licensure

NJ State Medical License 2003 - 2025
PA State Medical License 1997 - 2004
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

Fellow Infectious Diseases Society of America, 2018

Publications & Presentations

PubMed

20 citations
Anidulafungin: a new echinocandin for candidal infections.
Pola de la Torre, Annette C. Reboli> ;Expert Review of Anti-Infective Therapy. 2007 Feb 1
7 citations
Anidulafungin: a novel echinocandin for candida infections.
Pola de la Torre, Daniel K Meyer, Annette C. Reboli> ;Future Microbiology. 2008 Dec 11
6 citations
The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection.
Shweta Sharma, Katherine E. Schlusser, Pola de la Torre, Giuseppe Tambussi, Rika Draenert, Angie N Pinto, Julia A. Metcalf, James D. Neaton, Oliver Laeyendecker> ;AIDS. 2019 Jul 1
3 citations
Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial.
Katherine E. Schlusser, Shweta Sharma, Pola de la Torre, Giuseppe Tambussi, Rika Draenert, Angie N Pinto, Julia A. Metcalf, Danielle German, James D. Neaton, Oliver La...> ;AIDS and Behavior. 2018 Jul 1
1 citations
Nucleoside-sparing antiretroviral regimens.
Pola de la Torre, Jomy M. George, John D. Baxter> ;Current Infectious Disease Reports. 2014 Jun 1
Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy.
Hafkin JS Osborn MK Localio AR Amorosa VK Kostman JR Stern JJ De La Torre P Mounzer K Frank I Gross R Chang KM Lo Re V 3rd> ;J Viral Hepat. 2014 Apr
20 citations
Micafungin: an evidence-based review of its place in therapy
Pola de la Torre, Annette C. Reboli> ;Core Evidence. 2014 Feb 25
Join now to see all